Details for Patent: 4,301,146
Summary for Patent: 4,301,146
| Title: | Stabilization of 16-oxygenated prostanoic acid derivatives |
| Abstract: | A stable solid dosage form of the compound ±methyl(7-[3(α)-hydroxy-2-β-(4(RS)-4-hydroxy-4-methyl-trans-1-octen-1-yl)-oxycyclopent-1α-yl]heptanoate, said solid dosage form comprising from about 50 to about 500 parts of a polymer selected from the group consisting of hydroxypropylmethyl cellulose and polyvinylpyrolidone per part of said compound. |
| Inventor(s): | Dilip R. Sanvordeker |
| Assignee: | GDS NEWCO Inc A CORP OF DE , GD Searle LLC |
| Application Number: | US06/173,292 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; |
Drugs Protected by US Patent 4,301,146
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
